Make the right choices for you
Our Step by Step interactive guide outlines what happens following a diagnosis, to answer your questions and help you to understand what to expect.
Levetiracetam is used to treat epilepsy as it can help to prevent seizures from happening. It may also be referred to by its brand name Keppra®.
Levetiracetam is an epilepsy drug, NICE do not recommend it for treating brain tumours specifically. You should speak to your healthcare team before taking new medications or making changes to your existing brain tumour treatment.
It may be used in patients with brain tumours to manage seizures. Researchers have found this drug to be preferable for brain tumour patients compared to other anti-epileptic medications as it does not interact with other drugs the patients are likely to be taking.
There has been some early studies into whether levetiracetam can increase the effectiveness of temozolomide which appear to have shown positive results. Further research is required to know whether this is effective.
If you need someone to talk to or advice on where to get help, our Support and Information team is available by phone, email or live-chat.
By taking part in our Improving Brain Tumour Care surveys and sharing your experiences, you can help us improve treatment and care for everyone affected by a brain tumour.
If you have further questions, need to clarify any of the information on this page, or want to find out more about research and clinical trials, please contact our team:
0808 800 0004 (free from landlines and mobiles)
Phone lines open Mon-Fri, 09:00-17:00
You can also join our active online community - Join our online support groups.